Physician profile
Thomas John
NPI 1013095603
$1,196.20
in general payments reported to CMS, 2019-2025
21 companies · $625 in 2025
The $625 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.39 · 2020: $22.83 · 2021: $111 · 2022: $248 · 2023: $88.97 · 2024: $15.43 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $436.31 | 2019-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $160.18 | 2025 | Cardiomems, Assurity, Freestyle Libre 3 |
| Aimmune Therapeutics, INC. | $90.47 | 2025 | Zenpep, Vowst |
| Dexcom, INC. | $71.69 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $68.79 | 2025 | Evenity |
| Quidel Corporation | $54.63 | 2022 | |
| Tris Pharma INC | $29.64 | 2022 | |
| Ascendis Pharma Endocrinology INC | $29.13 | 2025 | Yorvipath |
| Amneal Pharmaceuticals LLC | $28.90 | 2025 | Unithroid |
| Sobi, INC | $25.75 | 2022 | |
| Chiesi USA, INC. | $25.01 | 2025 | Mycapssa |
| Exact Sciences Corporation | $24.69 | 2025 | Cologuard Collection Kit |
| Insulet Corporation | $19.98 | 2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.66 | 2019 | |
| Pfizer INC. | $19.41 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.66 | 2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $16.57 | 2025 | |
| Abbvie INC. | $15.43 | 2024 | |
| Sanofi Pasteur INC. | $14.72 | 2022 | |
| Medtronic, INC. | $14.34 | 2025 | Minimed 780g |
| Novo Nordisk INC | $14.24 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.